Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity
- PMID: 19095136
- DOI: 10.1016/j.jacc.2008.09.019
Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity
Abstract
Objectives: We sought to investigate the clinical-genetic profile of left-dominant arrhythmogenic cardiomyopathy (LDAC).
Background: In the absence of coronary disease and left ventricular (LV) systolic dysfunction, lateral T-wave inversion and arrhythmia of LV origin are often considered benign. Similarly, chest pain with enzyme release might be attributed to viral myocarditis. We hypothesized that these abnormalities might be manifestations of the "left-dominant" subtype of arrhythmogenic right ventricular cardiomyopathy.
Methods: The 42-patient cohort was established through clinical evaluation of individuals with unexplained (infero)lateral T-wave inversion, arrhythmia of LV origin, and/or proven LDAC/idiopathic myocardial fibrosis in the family.
Results: Patients presented from adolescence to age >80 years with arrhythmia or chest pain but not heart failure. Desmosomal mutations were identified in 8 of 24 families (15 of 33 patients). Magnetic resonance findings included LV late-enhancement in a subepicardial/midwall distribution, corresponding to fibrofatty replacement and fibrosis on histopathology. Fifty percent had previously been misdiagnosed with viral myocarditis, dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy, or idiopathic ventricular tachycardia. Arrhythmic events included presentation with ventricular fibrillatory arrest in 1 patient and 2 instances of sudden cardiac death during follow-up.
Conclusions: Arrhythmogenic cardiomyopathy is distinguished from DCM by a propensity towards arrhythmia exceeding the degree of ventricular dysfunction. The left-dominant subtype is under-recognized owing to misattribution to other disorders and lack of specific diagnostic criteria. Clinicians are alerted to the possibility of LDAC in patients of any age with unexplained arrhythmia of LV origin, (infero)lateral T-wave inversion, apparent DCM (with arrhythmic presentation), or myocarditis (chest pain and enzyme rise with unobstructed coronary arteries).
Comment in
-
Expanding the spectrum of arrhythmogenic cardiomyopathy.J Am Coll Cardiol. 2008 Dec 16;52(25):2188-9. doi: 10.1016/j.jacc.2008.08.062. J Am Coll Cardiol. 2008. PMID: 19095137 No abstract available.
-
Left dominant arrhythmogenic cardiomyopathy a new clinical entity without a typical substrate of myocardial damage.J Am Coll Cardiol. 2009 Apr 28;53(17):1570-1; author reply 1571-2. doi: 10.1016/j.jacc.2009.01.044. J Am Coll Cardiol. 2009. PMID: 19389573 No abstract available.
Similar articles
-
Emerging concepts in arrhythmogenic dilated cardiomyopathy.Heart Fail Rev. 2021 Sep;26(5):1219-1229. doi: 10.1007/s10741-020-09933-z. Heart Fail Rev. 2021. PMID: 32056050 Review.
-
[Arrhythmogenic left ventricular cardiomyopathy].Vnitr Lek. 2016 Fall;62(9):728-735. Vnitr Lek. 2016. PMID: 27715074 Review. Czech.
-
Left dominant arrhythmogenic cardiomyopathy: a morbid association of ventricular arrhythmias and unexplained infero-lateral T-wave inversion.J Electrocardiol. 2013 Jul-Aug;46(4):352-5. doi: 10.1016/j.jelectrocard.2013.03.011. Epub 2013 Apr 18. J Electrocardiol. 2013. PMID: 23684317
-
Left dominant arrhythmogenic cardiomyopathy a new clinical entity without a typical substrate of myocardial damage.J Am Coll Cardiol. 2009 Apr 28;53(17):1570-1; author reply 1571-2. doi: 10.1016/j.jacc.2009.01.044. J Am Coll Cardiol. 2009. PMID: 19389573 No abstract available.
-
Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy.Circulation. 2005 Aug 2;112(5):636-42. doi: 10.1161/CIRCULATIONAHA.104.532234. Circulation. 2005. PMID: 16061754
Cited by
-
Recurrent immunosuppressive-responsive myocarditis in a patient with desmoplakin cardiomyopathy: a case report.Eur Heart J Case Rep. 2024 Mar 13;8(3):ytae129. doi: 10.1093/ehjcr/ytae129. eCollection 2024 Mar. Eur Heart J Case Rep. 2024. PMID: 38638283 Free PMC article.
-
Arrhythmogenic Left Ventricular Cardiomyopathy: From Diagnosis to Risk Management.J Clin Med. 2024 Mar 22;13(7):1835. doi: 10.3390/jcm13071835. J Clin Med. 2024. PMID: 38610600 Free PMC article. Review.
-
Ventricular predominance in biventricular arrhythmogenic cardiomyopathy: Should new subtype criteria be recognized?Radiol Case Rep. 2024 Mar 28;19(6):2457-2463. doi: 10.1016/j.radcr.2024.03.014. eCollection 2024 Jun. Radiol Case Rep. 2024. PMID: 38585407 Free PMC article.
-
Imaging Features of Arrhythmogenic Cardiomyopathies.Radiographics. 2024 Apr;44(4):e230154. doi: 10.1148/rg.230154. Radiographics. 2024. PMID: 38512728
-
Prognostic impact of the findings of the genetic test in left dominant arrhythmogenic cardiomyopathy.Int J Cardiol Heart Vasc. 2024 Feb 27;51:101367. doi: 10.1016/j.ijcha.2024.101367. eCollection 2024 Apr. Int J Cardiol Heart Vasc. 2024. PMID: 38435382 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical